Study guide

5.5 Cannabis, GHB, Nitrites, and Nicotine Products

Certified Specialist in Poison Information CSPI

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pharmacology & Toxicology Principles

1.1 Toxicokinetics: Absorption, Distribution, Metabolism, and Elimination Alterations in Overdose 1.2 Toxicodynamics, Receptor Pharmacology, and Dose-Response Relationships 1.3 Cellular and Biochemical Mechanisms of Toxicity 1.4 Hepatic Biotransformation, Phase I/II Reactions, and CYP450 Interactions

2 Chapter 2: Poison Center Case Assessment Fundamentals

2.1 Exposure History: The Questions That Change Management 2.2 Toxicologic Calculations: Doses, Concentrations, and Conversions

3 Chapter 3: Analgesics, Opioids & Over-the-Counter Medications

3.1 Acetaminophen Overdose: Pathophysiology, Rumack-Matthew Nomogram, and NAC Protocols 3.2 Salicylates: Pathophysiology, Acid-Base Derangements, and Urinary Alkalinization 3.3 Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Miscellaneous OTC Analgesics 3.4 Opioids, Opioid Toxidrome, and Naloxone Titration 3.5 Cough and Cold Products, Antihistamines, Muscle Relaxants, and Local Anesthetics

4 Chapter 4: Psychotropic & Neurologic Medications

4.1 Tricyclic and Cyclic Antidepressants: Cardiotoxicity, ECG Findings, and Bicarbonate Therapy 4.2 SSRIs, SNRIs, Novel Antidepressants, and Serotonin Syndrome 4.3 Antipsychotics, Neuroleptic Malignant Syndrome, and Lithium Neurotoxicity 4.4 Benzodiazepines, Z-drugs, Barbiturates, and Major Anticonvulsants

5 Chapter 5: Cardiovascular Drugs & Substances of Abuse

5.1 Beta-Blockers, Calcium Channel Blockers, and High-Dose Insulin Euglycemia Therapy 5.2 Digoxin and Cardiac Glycosides: Mechanism, Arrhythmias, and Digoxin Immune Fab 5.3 Sympathomimetics, Cocaine, Amphetamines, Synthetic Cannabinoids, and Hallucinogens 5.4 Caffeine, Theophylline, and Over-the-Counter Stimulants 5.5 Cannabis, GHB, Nitrites, and Nicotine Products

6 Chapter 6: Endocrine, Antimicrobial & Miscellaneous Medications

6.1 Antidiabetic Agents, Metformin Lactic Acidosis, and Thyroid Hormone 6.2 Antimicrobials, Vitamins and Minerals, and Veterinary Products

7 Chapter 7: Household, Chemical & Inhalational Toxins

7.1 Caustic and Corrosive Ingestions: Acids vs. Alkalis, Tissue Necrosis, and Endoscopic Grading 7.2 Cleaning Products, Personal Care Products, and Household Chemicals 7.3 Hydrocarbons and Halogenated Solvents: Aspiration Risks and Myocardial Sensitization 7.4 Carbon Monoxide, Cyanide, Hydrogen Sulfide, and Inhalational Irritants

8 Chapter 8: Pesticides, Heavy Metals & Toxic Alcohols

8.1 Organophosphates, Carbamates, Pyrethroids, and Cholinesterase Antidotes 8.2 Rodenticides, Herbicides, Repellents, and Other Pesticides 8.3 Ethylene Glycol, Methanol, and Isopropanol: Metabolism, Osmolal Gaps, and Fomepizole 8.4 Lead, Mercury, Arsenic, Iron Toxicity, and Chelation Protocols

9 Chapter 9: Toxic Plants, Mushrooms & Foodborne Toxins

9.1 Toxic Plants: Cardiac Glycosides, Anticholinergics, Nicotinics, and Sodium Channel Activators 9.2 Oxalate, Irritant, Hallucinogenic, and Stimulant Plants 9.3 Mushroom Poisoning: Amatoxins, Monomethylhydrazine, Muscarine, and Coprine 9.4 Scombroid, Ciguatera, Tetrodotoxin, Paralytic Shellfish, and Botulism 9.5 Bacterial Foodborne Illness and Food Poisoning Triage

10 Chapter 10: Envenomations & Bites

10.1 North American Pit Vipers (Crotalinae): Envenomation Assessment and Antivenom Management 10.2 Elapid Snakebites (Coral Snakes): Neurotoxicity, Clinical Course, and Antivenin 10.3 Black Widow, Brown Recluse Spiders, and Bark Scorpion Stings 10.4 Hymenoptera Stings, Ticks, and Other Arthropods 10.5 Marine Envenomations: Jellyfish, Stingrays, Catfish, and Lionfish

11 Chapter 11: Clinical Assessment, Toxidromes & Triage

11.1 Recognition of Classic Toxidromes and Vital Sign Pattern Analysis 11.2 Severity Assessment, Exposure Urgency, and Poison Center Telephone Triage Flow 11.3 Home Observation vs. Emergency Department Referral Decision-Making 11.4 Diagnostic Toxicology: Acid-Base Analysis, Gaps, ECG Intervals, and Drug Testing

12 Chapter 12: Decontamination, Antidotes & Elimination

12.1 Gastrointestinal Decontamination: Activated Charcoal, Whole Bowel Irrigation, and Contraindications 12.2 Essential Poison Center Antidotes: Indications, Mechanisms, and Titration Pearls 12.3 Enhanced Elimination: Urinary Alkalinization, MDAC, Hemodialysis, and Hemoperfusion 12.4 Resuscitation and Supportive Care: Seizures, Hyperthermia, and Hemodynamic Shock

13 Chapter 13: Pediatric Poisoning & High-Risk Hazards

13.1 Pediatric "One-Pill-Can-Kill" Agents and Pediatric Toxic Dose Thresholds 13.2 Button Batteries, Rare-Earth Magnets, and Expandable Foreign Bodies 13.3 Developmental Ingestion Patterns, Liquid Detergent Pods, and Essential Oils

14 Chapter 14: Communication, NPDS Documentation & Prevention

14.1 Emergency Call Communication, Panicked Callers, and Healthcare Provider Consultations 14.2 National Poison Data System (NPDS) Coding Standards and Medical Outcome Categorization 14.3 Scheduled Follow-up Protocols, Medical Toxicologist Consultation Triggers, and Public Health Surveillance 14.4 Evidence-Based Poison Prevention, PPPA Regulations, and Community Outreach

5.5 Cannabis, GHB, Nitrites, and Nicotine Products

Key Takeaways Explain This Topic AI

Edible cannabis products are a leading cause of pediatric intensive care admission among recreational drug exposures, with young children developing ataxia, profound somnolence, and occasionally respiratory depression after delayed absorption.

Gamma-hydroxybutyrate produces deep coma with preserved vital signs and an abrupt spontaneous awakening after 2 to 4 hours, and its withdrawal syndrome resembles severe alcohol withdrawal and may require very large benzodiazepine doses.

Nicotine causes biphasic nicotinic effects: early vomiting, tachycardia, and hypertension, followed by weakness, bradycardia, and paralysis, and concentrated electronic cigarette liquid can deliver a lethal dose to a small child in a swallow.

Volatile alkyl nitrites, used as inhalants, cause methemoglobinemia and syncope, while nitrite ingestion has caused fatal methemoglobinemia treated with methylene blue.

Most single-substance cannabis exposures in adults need only reassurance and a quiet environment, so triage focuses on the child who ingested an edible, the patient with an unknown co-ingestant, and the synthetic cannabinoid user with agitation or seizures.

Last updated: September 2026

Cannabis and Delta-9-Tetrahydrocannabinol

Delta-9-tetrahydrocannabinol is a partial agonist at CB1 (central) and CB2 (peripheral immune) receptors. Partial agonism, plus the presence of cannabidiol in plant material, explains why natural cannabis has a wide margin of safety in adults.

Adults

Expected effects are euphoria, conjunctival injection, tachycardia, dry mouth, increased appetite, and impaired coordination and reaction time. Adverse presentations include panic and paranoia, acute psychosis, and cannabinoid hyperemesis syndrome : cyclical vomiting in a chronic heavy user who describes compulsive hot bathing for relief, often responsive to topical capsaicin, droperidol or haloperidol, and benzodiazepines rather than to standard antiemetics.

Children and Edibles

Edible products are the pediatric problem. They look like candy or baked goods, contain many adult doses per package, and absorb slowly so the child appears fine and then deteriorates.

Onset after ingestion is 30 minutes to 3 hours , with peak effects at 2 to 4 hours and effects lasting 8 to 12 hours or longer.

Young children present with ataxia, marked lethargy or coma, mydriasis, tachycardia , and sometimes hypotonia, apnea, or seizures.

There is no reliable safe pediatric threshold: a single 10 mg edible serving can sedate a toddler, and many packages contain 100 mg or more of tetrahydrocannabinol.

Management is airway assessment and observation; most children recover with supportive care, but respiratory depression mandates emergency evaluation for any symptomatic child.

Delta-8 and Related Semi-Synthetic Cannabinoids

Products labeled delta-8 or delta-10 tetrahydrocannabinol are chemically converted from hemp-derived cannabidiol, sold with little regulation, and frequently mislabeled for potency. Pediatric exposures behave like high-dose edible exposures.

Synthetic Cannabinoid Receptor Agonists

These are full agonists with far higher CB1 affinity and no cannabidiol, which is why they behave nothing like cannabis: severe agitation, psychosis, seizures, tachydysrhythmias, hypokalemia, acute kidney injury, myocardial ischemia, and death. Some batches have been adulterated with brodifacoum , producing severe coagulopathy. Treatment is benzodiazepines and supportive care, with coagulation studies if bleeding occurs.

Gamma-Hydroxybutyrate and Its Precursors

Gamma-hydroxybutyrate (GHB) is an endogenous neurotransmitter that acts at GHB receptors and, at higher concentrations, at GABA-B receptors. Two industrial chemicals are converted to GHB after ingestion: gamma-butyrolactone (GBL) , found in some cleaners and solvents, and 1,4-butanediol , which is metabolized by alcohol dehydrogenase.

Acute Overdose

Deep coma with relatively preserved vital signs , often with bradycardia, hypothermia, myoclonic jerks, and vomiting.

A hallmark is abrupt, spontaneous awakening 2 to 4 hours after ingestion , sometimes with agitation, in a patient who appeared moribund.

The steep dose-response curve means the difference between euphoria and apnea is small, and co-ingested ethanol markedly increases the risk.

Management is airway protection and observation. Flumazenil and naloxone are ineffective. Persistent coma beyond about 6 hours should prompt a search for another cause.

Withdrawal

Daily users (often dosing every 2 to 4 hours around the clock) develop withdrawal within hours of the last dose: tremor, tachycardia, hypertension, insomnia, hallucinations, delirium, and seizures. It resembles severe alcohol withdrawal, can be fatal, and often requires very high cumulative benzodiazepine doses , sometimes with barbiturates or propofol.

Volatile Alkyl Nitrites ("Poppers")

Amyl, butyl, and isobutyl nitrite are inhaled as vasodilators and euphoriants.

Inhalation causes flushing, headache, tachycardia, and syncope from abrupt vasodilation, and it is dangerous with phosphodiesterase-5 inhibitors.

Ingestion causes clinically significant methemoglobinemia : cyanosis unresponsive to oxygen, chocolate-brown blood, and a pulse oximetry reading that plateaus near 85%. Treatment is methylene blue 1 to 2 mg/kg IV .

Sodium nitrite purchased online has caused deaths in intentional ingestions; these patients need immediate methylene blue and often exchange transfusion if severe.

Nicotine and Tobacco Products

Nicotine is an agonist at nicotinic acetylcholine receptors at autonomic ganglia, the neuromuscular junction, and the central nervous system. Its toxicity is biphasic .

Phase Mechanism Findings

Early (stimulation) Ganglionic and central activation Nausea and vomiting (often within 15 to 60 minutes), salivation, pallor, diaphoresis, tachycardia, hypertension, tremor, agitation, seizures

Late (blockade) Persistent depolarization causes receptor blockade Bradycardia, hypotension, weakness, fasciculations then flaccid paralysis, respiratory muscle failure, coma

Product Content and Thresholds

  • Product Approximate Nicotine Content
  • One cigarette 10 to 15 mg total (much is lost in smoke)
  • One cigarette butt 5 to 7 mg
  • Chewing tobacco, 1 g 6 to 8 mg
  • Nicotine gum or lozenge 2 to 4 mg per piece
  • Nicotine pouch 3 to more than 40 mg per pouch
  • Electronic cigarette liquid Commonly 3 to 60 mg/mL; a 30 mL bottle at 36 mg/mL contains over 1,000 mg

Children who ingest about 0.2 mg/kg or more warrant medical evaluation if symptomatic, and many centers refer any swallow of liquid nicotine. Mild symptoms have appeared near 0.8 mg/kg, and the estimated lowest lethal oral dose for children under 5 is roughly 1 to 14 mg/kg . The older "60 mg is lethal in an adult" figure is now considered a substantial underestimate for adults.

The dangerous exposures are concentrated electronic cigarette liquid (a swallow can far exceed a toddler's toxic dose, and dermal absorption from a spill also matters), pouches and lozenges, and multiple cigarette butts.

Management is airway support and aggressive antiemetic and fluid therapy. Vomiting is partly protective. Activated charcoal binds nicotine but is often impractical because of emesis. Atropine treats symptomatic bradycardia and secretions; benzodiazepines treat seizures; assisted ventilation is required for paralysis.

Green Tobacco Sickness

Field workers harvesting wet tobacco absorb nicotine transdermally and develop nausea, vomiting, headache, dizziness, and weakness. Treatment is removal from exposure, skin washing, and rehydration.

Triage Summary

  • Exposure Home Observation Possible? Key Action
  • Adult single-substance cannabis Usually yes Quiet environment, reassurance, follow-up call

Child with an edible or delta-8 product No if any symptom; low-dose asymptomatic exposures may be observed with close follow-up Watch for delayed onset up to 3 hours, then prolonged effects

  • Synthetic cannabinoid No Benzodiazepines, potassium, kidney function, coagulation if bleeding
  • GHB, GBL, 1,4-butanediol No Airway, expect abrupt awakening; investigate persistent coma
  • Nitrite ingestion No Co-oximetry, methylene blue

Concentrated nicotine liquid in a child No Emergency evaluation, antiemetics, monitoring for the late paralytic phase

One or two cigarette butts in a child Often yes Expect vomiting; follow-up call